The Bureau of International Narcotics and Law Enforcement Affairs' Office of Policy, Planning and Coordination manages public affairs and public outreach, congressional affairs, multilateral affairs (United Nations, Organization of American States, Group of Eight, European Union, and others) as well as special projects, including coordination of the annual International Narcotics Control Strategy Report and the President’s annual List of Major Drug Source and Transit Countries. Due to INL’s large foreign assistance budget and assistance programs in high-profile areas, such as Iraq, Afghanistan, Mexico, and Colombia, the Bureau receives much attention from the U.S. Congress and media.
In keeping with the Administration’s goal of increasing U.S. cooperation with international multilateral organizations, INL works with the United Nations Office of Drug and Crime (UNODC) and other international and regional organizations and bodies to help set criminal law standards, pool resources, share best practices and other expertise, and close off safe havens (e.g., weak or corrupt states, under-governed areas) to crime, drug, and terrorist groups. INL leads the U.S. Delegation to the annual sessions of the UN Commission on Narcotic Drugs and the UN Commission on Crime Prevention and Criminal Justice, the UN’s highest policy bodies on international drugs and crime. INL also leads the U.S. delegations to the Conferences of Parties that serve as the monitoring and implementing bodies for the UN Conventions Against Transnational Organized Crime and Against Corruption. At the same time, INL provides funding support to the UN Office on Drugs and Crime (UNODC), which provides technical assistance and capacity building on a global scale in order to enable countries to strengthen their law enforcement and judicial capacity to investigate crime and prosecute offenders, as well as to increase their ability to provide comprehensive drug abuse treatment and rehabilitation programs. For more information on UNODC programs and activities, please visit UNODC’s website at www.unodc.org. To enhance counter-drug and anti-crime cooperation and coordination with the European Union, INL leads the U.S. delegation on counterdrugs and co-leads the U.S. Delegation on justice and homeland affairs that meet regularly with European Union counterparts to exchange views and information and coordinate policies and programs. INL also co-leads the U.S. delegation to the Group of Eight’s (G-8) Roma-Lyon Group on Counter-Terrorism and Counter-Crime, which draws on a broad range of experts to advance practical cooperation to counter a wide range of criminal and terrorist activity. The group often develops best practices that are then shared with other partners and international organizations, including UNODC, as well as initiates diplomatic outreach, coordinates assistance activities and advances law enforcement cooperation. To learn more about the G-8, please visit http://g8.gc.ca/home/. INL also plays a leading political role and major donor in the OAS’s Inter-American Commission Against Drug Abuse (CICAD), where the INL Assistant Secretary currently serves as Commission President. CICAD serves as the focal point for Multilateral Evaluation Mechanism (MEM), which evaluates and provides recommendations for improving the drug control measures undertaken by OAS member states, bearing in mind the commitments enshrined in the three UN drug control treaties. It also provides drug control technical assistance and capacity building assistance to countries in the Western Hemisphere. INL funding is used to support the MEM, as well as these related assistance activities. More information on CICAD is available at http://www.cicad.oas.org/en/.
The Office also serves as Bureau Coordinator for the annual International Narcotics Control Strategy Reports (INCSR), which assesses the counter-drug and anti-money laundering policies and practices of more than 130 counties. The full INCSR reports are available at http://www.state.gov/j/inl/rls/nrcrpt. The Office also serves as the USG coordinator of the annual Presidential List of Major Drug Source and Transit Countries. As part of this process, countries that are deemed to have failed demonstrably to meet their international drug control obligations are subject to a broad range of sanctions unless the President approves a national security waiver.